ID

25353

Descripción

Efficacy and Safety of Statin on the Course of Progressive Smoldering Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT00503763

Link

https://clinicaltrials.gov/show/NCT00503763

Palabras clave

Versiones (1)
  1. 2/9/17 2/9/17 -
Subido en

2 de septiembre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Smoldering Multiple Myeloma NCT00503763

Inglés

Eligibility Smoldering Multiple Myeloma NCT00503763

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. patients fulfilling the criteria of smm. (see appendix i)
Descripción

Smoldering myeloma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1531608
2. patients with progressive smoldering myeloma. (see appendix ii)
Descripción

Smoldering myeloma Progressive

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1531608
UMLS CUI [1,2]
C0205329
3. age 18-80 years.
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
4. signed informed consent prior to patient recruitment.
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. patients fulfilling diagnostic criteria of active mm .(see appendix i)
Descripción

Multiple Myeloma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0026764
2. patients fulfilling diagnostic criteria of: solitary myeloma or non secreting myeloma or oligosecretory myeloma or light chain myeloma.
Descripción

Plasmacytoma | Non-secretory myeloma | Myeloma M Protein Very low | Light chain myeloma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032131
UMLS CUI [2]
C0456845
UMLS CUI [3,1]
C0026764
UMLS CUI [3,2]
C0700271
UMLS CUI [3,3]
C0442811
UMLS CUI [4]
C0456844
3. patients on statin treatment on the day of recruitment.
Descripción

Statins

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0360714
4. patients on chemotherapy or receiving steroids.
Descripción

Chemotherapy | Steroids

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C0038317
5. patients with any contraindication to statin treatment:
Descripción

Medical contraindication Statins

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0360714
known intolerance or hypersensitivity to statin.
Descripción

Intolerance to Statins | Statin allergy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1744706
UMLS CUI [1,2]
C0360714
UMLS CUI [2]
C0571873
sgot or sgpt above 1.5 times of upper normal level (unl).
Descripción

Aspartate aminotransferase increased | Alanine aminotransferase increased

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0151904
UMLS CUI [2]
C0151905
cpk above unl
Descripción

Creatine phosphokinase serum increased

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0241005
concomitant treatment with macrolides and or antifungal agents (ketoconazole)
Descripción

Macrolides | Antifungal Agents | Ketoconazole

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0282563
UMLS CUI [2]
C0003308
UMLS CUI [3]
C0022625
creatinine level above 1.5 mg%
Descripción

Creatinine measurement, serum

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201976
any severe and/or uncontrolled medical disease (i.e., uncontrolled diabetes, chronic renal disease, or active uncontrolled infection).
Descripción

Disease Severe | Disease Uncontrolled | Diabetic - poor control | Chronic Kidney Diseases | Communicable Disease Uncontrolled

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C0205318
UMLS CUI [3]
C0421258
UMLS CUI [4]
C1561643
UMLS CUI [5,1]
C0009450
UMLS CUI [5,2]
C0205318
6. patients with second primary malignancy (except for non melanoma skin malignancy) unless they have been disease free for at least five years.
Descripción

Second Primary Cancers | Exception Skin carcinoma | Exception Disease Free of

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0751623
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0699893
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0012634
UMLS CUI [3,3]
C0332296
7. patients who have a history of alcohol or drug abuse.
Descripción

Substance Use Disorders

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0038586
8. patients who are mentally or physically unable to comply with all aspects of the study.
Descripción

Protocol Compliance Unable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0525058
UMLS CUI [1,2]
C1299582
9. participation to an investigational drug trial
Descripción

Study Subject Participation Status | Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0013230
Volver a la parte superior de la página

Similar models

Eligibility Smoldering Multiple Myeloma NCT00503763

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Smoldering myeloma
Item
1. patients fulfilling the criteria of smm. (see appendix i)
boolean
C1531608 (UMLS CUI [1])
Smoldering myeloma Progressive
Item
2. patients with progressive smoldering myeloma. (see appendix ii)
boolean
C1531608 (UMLS CUI [1,1])
C0205329 (UMLS CUI [1,2])
Age
Item
3. age 18-80 years.
boolean
C0001779 (UMLS CUI [1])
Informed Consent
Item
4. signed informed consent prior to patient recruitment.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Multiple Myeloma
Item
1. patients fulfilling diagnostic criteria of active mm .(see appendix i)
boolean
C0026764 (UMLS CUI [1])
Plasmacytoma | Non-secretory myeloma | Myeloma M Protein Very low | Light chain myeloma
Item
2. patients fulfilling diagnostic criteria of: solitary myeloma or non secreting myeloma or oligosecretory myeloma or light chain myeloma.
boolean
C0032131 (UMLS CUI [1])
C0456845 (UMLS CUI [2])
C0026764 (UMLS CUI [3,1])
C0700271 (UMLS CUI [3,2])
C0442811 (UMLS CUI [3,3])
C0456844 (UMLS CUI [4])
Statins
Item
3. patients on statin treatment on the day of recruitment.
boolean
C0360714 (UMLS CUI [1])
Chemotherapy | Steroids
Item
4. patients on chemotherapy or receiving steroids.
boolean
C0392920 (UMLS CUI [1])
C0038317 (UMLS CUI [2])
Medical contraindication Statins
Item
5. patients with any contraindication to statin treatment:
boolean
C1301624 (UMLS CUI [1,1])
C0360714 (UMLS CUI [1,2])
Intolerance to Statins | Statin allergy
Item
known intolerance or hypersensitivity to statin.
boolean
C1744706 (UMLS CUI [1,1])
C0360714 (UMLS CUI [1,2])
C0571873 (UMLS CUI [2])
Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
sgot or sgpt above 1.5 times of upper normal level (unl).
boolean
C0151904 (UMLS CUI [1])
C0151905 (UMLS CUI [2])
Creatine phosphokinase serum increased
Item
cpk above unl
boolean
C0241005 (UMLS CUI [1])
Macrolides | Antifungal Agents | Ketoconazole
Item
concomitant treatment with macrolides and or antifungal agents (ketoconazole)
boolean
C0282563 (UMLS CUI [1])
C0003308 (UMLS CUI [2])
C0022625 (UMLS CUI [3])
Creatinine measurement, serum
Item
creatinine level above 1.5 mg%
boolean
C0201976 (UMLS CUI [1])
Disease Severe | Disease Uncontrolled | Diabetic - poor control | Chronic Kidney Diseases | Communicable Disease Uncontrolled
Item
any severe and/or uncontrolled medical disease (i.e., uncontrolled diabetes, chronic renal disease, or active uncontrolled infection).
boolean
C0012634 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0421258 (UMLS CUI [3])
C1561643 (UMLS CUI [4])
C0009450 (UMLS CUI [5,1])
C0205318 (UMLS CUI [5,2])
Second Primary Cancers | Exception Skin carcinoma | Exception Disease Free of
Item
6. patients with second primary malignancy (except for non melanoma skin malignancy) unless they have been disease free for at least five years.
boolean
C0751623 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0012634 (UMLS CUI [3,2])
C0332296 (UMLS CUI [3,3])
Substance Use Disorders
Item
7. patients who have a history of alcohol or drug abuse.
boolean
C0038586 (UMLS CUI [1])
Protocol Compliance Unable
Item
8. patients who are mentally or physically unable to comply with all aspects of the study.
boolean
C0525058 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
Study Subject Participation Status | Investigational New Drugs
Item
9. participation to an investigational drug trial
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial